MACM
March Altus Capital Management Portfolio holdings
AUM
$16M
This Quarter Return
+4.89%
1 Year Return
+18.92%
3 Year Return
+153.93%
5 Year Return
–
10 Year Return
–
AUM
$10.9M
AUM Growth
+$10.9M
(-36%)
Cap. Flow
-$1.64M
Cap. Flow
% of AUM
-15.08%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
16
New
2
Increased
5
Reduced
3
Closed
6
Top Buys
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$1.64M |
| 2 |
Incyte
INCY
|
$804K |
| 3 |
ATHN
Athenahealth, Inc.
ATHN
|
$789K |
| 4 |
DexCom
DXCM
|
$758K |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$630K |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$1.69M |
| 2 |
MDCO
Medicines Co
MDCO
|
$838K |
| 3 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$816K |
| 4 |
MDVN
MEDIVATION, INC.
MDVN
|
$799K |
| 5 |
Neurocrine Biosciences
NBIX
|
$692K |
Sector Composition
| 1 | Healthcare | 78.18% |
| 2 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALXN
1
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $1.64M | 15.09% |
+8,599
| New | +$1.64M |
|
|
2
Incyte
INCY
$16.8B
| $1.6M | 14.72% |
14,756
+7,412
| +101% | +$804K |
|
|
3
Regeneron Pharmaceuticals
REGN
$61.3B
| $1.58M | 14.56% |
2,916
+1,160
| +66% | +$630K |
|
|
4
DexCom
DXCM
$29.1B
| $1.56M | 14.35% |
19,046
+9,252
| +94% | +$758K |
|
|
PETX
5
DELISTED
Aratana Therapeutics, Inc.
PETX
| $1.22M | 11.21% |
218,515
+107,978
| +98% | +$602K |
|
6
Acadia Pharmaceuticals
ACAD
$4.33B
| $1.06M | 9.77% |
29,801
-19,024
| -39% | -$678K |
|
|
ATHN
7
DELISTED
Athenahealth, Inc.
ATHN
| $789K | 7.26% |
+4,900
| New | +$789K |
|
8
Eli Lilly
LLY
$659B
| $750K | 6.9% |
8,898
-7,946
| -47% | -$670K |
|
|
AERI
9
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $364K | 3.35% |
14,962
-16,000
| -52% | -$389K |
|
10
Edwards Lifesciences
EW
$48B
| $303K | 2.79% |
38,322
+4,253
| +12% | +$33.6K |
|
|
11
Gilead Sciences
GILD
$140B
| – | – |
-17,162
| Closed | -$1.69M |
|
|
12
Neurocrine Biosciences
NBIX
$14.1B
| – | – |
-17,386
| Closed | -$692K |
|
13
United Therapeutics
UTHR
$18.3B
| – | – |
-2,500
| Closed | -$328K |
|
|
MNK
14
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| – | – |
-12,769
| Closed | -$816K |
|
|
MDCO
15
DELISTED
Medicines Co
MDCO
| – | – |
-22,077
| Closed | -$838K |
|
|
MDVN
16
DELISTED
MEDIVATION, INC.
MDVN
| – | – |
-18,794
| Closed | -$799K |
|